Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression
about
Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart.miR-34a Targets HDAC1-Regulated H3K9 Acetylation on Lipid Accumulation Induced by Homocysteine in Foam Cells.Macrophage polarization in response to epigenetic modifiers during infection and inflammation.Myocardial stress and autophagy: mechanisms and potential therapies.Autophagy modulation: a potential therapeutic approach in cardiac hypertrophy.Ketogenic Diet Reduces Midlife Mortality and Improves Memory in Aging Mice.Class I HDACs control a JIP1-dependent pathway for kinesin-microtubule binding in cardiomyocytes.Leptin accelerates the pathogenesis of heterotopic ossification in rat tendon tissues via mTORC1 signaling.Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism.Inhibition of HDAC3 prevents diabetic cardiomyopathy in OVE26 mice via epigenetic regulation of DUSP5-ERK1/2 pathway.Loss of Akap1 Exacerbates Pressure Overload-Induced Cardiac Hypertrophy and Heart Failure.MGCD0103 induces apoptosis and simultaneously increases the expression of NF-κB and PD-L1 in classical Hodgkin's lymphomaFood Bioactive HDAC Inhibitors in the Epigenetic Regulation of Heart FailureDifferences in Functional Expression of Connexin43 and Na1.5 by Pan- and Class-Selective Histone Deacetylase Inhibition in HeartThe Crosstalk between Acetylation and Phosphorylation: Emerging New Roles for HDAC Inhibitors in the Heart
P2860
Q33705752-B1FF00D7-11A1-4641-8E1C-A1A2B11E21ECQ38796278-4FF73B47-C005-446F-8006-BB1A2F1BF00AQ38935540-E4F35B35-4077-4665-A631-F11C99D80041Q39210684-3563CC84-741D-4C8D-931F-BEA07A36923AQ39347380-5F6D5E5D-D807-4E42-BB39-71BA9CCEA9C7Q40055606-3115E7A0-40C7-4B46-B035-ED732C365054Q47832574-E7739EE1-798B-4DCA-8211-AD78B4CA9D41Q48278243-475A83F2-F2D0-428D-8CCB-92D2115E6925Q50045909-21D90773-13DE-4DB0-92CD-C012E38F6B96Q50630504-4DF34D2F-35E5-4E06-8895-0FE727700FB0Q54976477-B29DF23D-2746-4BB6-80AD-53A7A25B306DQ57787094-AE3B4122-84E7-4794-B654-EB0C6C3E73B9Q58766782-CF52FE96-6D69-4237-8B87-FC56ACD7D0E0Q58800432-DF7FFD7E-91F8-4E4B-8BED-FD9BBD5E5C65Q60927794-799f2250-464a-49ca-16e9-5c5feafe3246
P2860
Inhibition of class I histone deacetylases blunts cardiac hypertrophy through TSC2-dependent mTOR repression
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Inhibition of class I histone ...... TSC2-dependent mTOR repression
@ast
Inhibition of class I histone ...... TSC2-dependent mTOR repression
@en
type
label
Inhibition of class I histone ...... TSC2-dependent mTOR repression
@ast
Inhibition of class I histone ...... TSC2-dependent mTOR repression
@en
prefLabel
Inhibition of class I histone ...... TSC2-dependent mTOR repression
@ast
Inhibition of class I histone ...... TSC2-dependent mTOR repression
@en
P2093
P2860
P1433
P1476
Inhibition of class I histone ...... TSC2-dependent mTOR repression
@en
P2093
Beverly A Rothermel
Cyndi R Morales
David Rotter
Geoffrey W Cho
Jay W Schneider
Joseph A Hill
Sergio Lavandero
Soo Young Kim
P2860
P356
10.1126/SCISIGNAL.AAD5736
P50
P577
2016-04-05T00:00:00Z